Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice-Reference-Cited by-同舟云学术

Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice

Published:2020-10-27 Issue:6 Volume:39 Page:565-575
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Marutani Yuka,Mizoshita Tsutomu,Sugiyama Tomoya,Togawa Shozo,Katano Takahito,Yamada Tomonori,Hirata Yoshikazu,Kimura Yoshihide,Miyaki Tomokatsu,Inoue Yusuke,Suzuki Erina,Sasaki Makoto,Kataoka Hiromi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s12664-020-01092-1.pdf

Reference33 articles.

1. Dulai PS, Singh S, Casteele NV, Boland BS, Sandborn WJ. How will evolving future therapies and strategies change how we position the use of biologics in moderate to severely active inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:998–1009.

2. Taxonera C, Rodriguez C, Bertoletti F, et al. Clinical outcomes of golimumab as first, second or third anti-TNF agent in patients with moderate-to-severe ulcerative colitis. Inflamm Bowel Dis. 2017;23:1394–402.

3. Vickers AD, Ainsworth C, Mody R, et al. Systematic review with network meta-analysis: comparative efficacy of biologics in the treatment of moderately to severely active ulcerative colitis. PLoS One. 2016;11:e0165435.

4. Kawalec P, Pilc A. An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis. Arch Med Sci. 2016;12:1097–109.

5. Peyrin-Biroulet L, Laclotte C, Roblin X, Bigard MA. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. World J Gastroenterol. 2007;13:2328–32.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab/golimumab/infliximab;Reactions Weekly;2021-04

2. Editorial commentary on the Indian Journal of Gastroenterology November-December 2020;Indian Journal of Gastroenterology;2020-12